loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: 1,2-diaminocyclohexane platinum oxalate

    Menu

    1,2 Diaminocyclohexane Platinum Oxalate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 34,039Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22160 / DOSAGE - INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OXALIPLATIN(UNII: 04ZR38536J)
    (OXALIPLATIN - UNII:04ZR38536J)     		OXALIPLATIN100mg in 20 | 50mg in 10

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    APP Pharmaceuticals, LLC
    Alvogen Inc.
    Athenex Pharmaceutical Division, LLC.
    Baxter Healthcare Corporation
    BluePoint Laboratories
    Breckenridge Pharmaceutical, Inc.
    Cipla USA Inc.
    Mylan Institutional LLC
    NorthStar RxLLC
    Sandoz Inc.
    Sanja Pharmaceuticals Company
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)          
    Water(059QF0KO0R)